New Developments in the Management of Schizophrenia and Bipolar Disorder: Potential Use of Cariprazine

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s64915
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Global Improvement With Cariprazine in the Treatment of Bipolar I Disorder and Schizophrenia: A Pooled Post Hoc Analysis

International Journal of Clinical Practice
Medicine
2017English

Use of the Web in the Self-Management of Bipolar Disorder

Acta Neuropsychiatrica
PsychiatryMental HealthBiological Psychiatry
2006English

Schizophrenia and Bipolar Disorder in Urban Areas

Mental Health and Learning Disabilities Research and Practice
2007English

Use of Schizophrenia and Bipolar Disorder Polygenic Risk Scores to Identify Psychotic Disorders

British Journal of Psychiatry
MedicinePsychiatryMental Health
2018English

Perisylvian GABA Levels in Schizophrenia and Bipolar Disorder

Neuroscience Letters
Neuroscience
2017English

Cognitive Vulnerability Indicators in Bipolar Disorder and Schizophrenia

Annals of General Psychiatry
PsychiatryMental Health
2008English

Exploring the WNT Signaling Pathway in Schizophrenia and Bipolar Disorder

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2018English

Mitochondrial Dysfunction and Pathology in Bipolar Disorder and Schizophrenia

International Journal of Developmental Neuroscience
Developmental NeuroscienceDevelopmental Biology
2010English

Contextual Social Cognition Impairments in Schizophrenia and Bipolar Disorder

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy